Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | Director | Jun 11, 2026 | Jun 16, 2026 |
| Jazz Pharmaceuticals plc (JAZZ) | Former Director | May 31, 2007 | Mar 13, 2012 |
Also a director at
Jazz Pharmaceuticals plc (JAZZ) (no filing in the last 18 months)
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jun 15, 2026, Parabilis Medicines, Inc.: bought 9,065 shares for $240K (some held indirectly). 1 filing: 1
- Jun 12, 2026, Parabilis Medicines, Inc.: bought 8,435 shares for $233K (some held indirectly). 1 filing: 1
- Jun 11, 2026, Parabilis Medicines, Inc.: bought 12,500 shares for $250K (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.